Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.

Janet Pope; Kyle M Walker; Faye de Leon; Louise Vanderhoek; Shannon Seney; Kelly L Summers

首页> 外文期刊>Rheumatology >Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.

【24h】

Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.

机译：利用伊马替尼研究的数据使用来自IMATINIB研究的活性弥漫性系统硬化症早期（概念证明）试验的细胞因子和临床结果之间的相关性。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

http://clinicaltrials.gov/show/NCT01545427.

机译：HTTP://clinical trials.gov/show/n CT01545427.

著录项

来源
《Rheumatology 》 |2014年第10期| 共5页
作者
Janet Pope; Kyle M Walker; Faye de Leon; Louise Vanderhoek; Shannon Seney; Kelly L Summers;
展开▼
作者单位

Division of Rheumatology Department of Medicine Schulich School of Medicine &

Dentistry;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study. [J] . Janet Pope, Kyle M Walker, Faye de Leon, Rheumatology . 2014 ,第10期

机译：使用伊马替尼研究的数据进行的活动性弥漫性系统硬化的早期阶段（概念验证）试验中细胞因子变化与临床结果之间的相关性。
2. Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center [J] . Janet Pope, Donna McBain, Lisa Petrlich, Arthritis & Rheumatism . 2011 ,第11期

机译：伊马替尼治疗活动性弥漫性皮肤系统性硬化症：在单个中心进行的为期六个月，随机，双盲，安慰剂对照，概念验证的试验研究的结果
3. Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. [J] . Pope J, McBain D, Petrlich L, Arthritis and Rheumatism . 2011 ,第11期

机译：伊马替尼在活动性弥漫性皮肤系统性硬化症中的作用：在一个中心进行的为期六个月，随机，双盲，安慰剂对照，概念验证的试验研究的结果。
4. Correlation of optical coherence elastography with clinical evaluation of systemic sclerosis [C] . Chih-Hao Liu, Christopher Smith, Alexander Schill, Optical Elastography and Tissue Biomechanics VI . 2019

机译：光学相干弹性成像与系统性硬化症临床评估的相关性
5. Immunoregulatory Activities of Novel Anti-inflammatory Cytokine Interleukin-35 on Systemic Lupus Erythematosus: Clinical and in vivo Study. [D] . Cai, Zhe. 2015

机译：新型抗炎细胞因子白细胞介素35对系统性红斑狼疮的免疫调节活性：临床和体内研究。
6. Extended report: Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year phase IIa single-arm open-label clinical trial [O] . Robert F Spiera, Jessica K Gordon, Jamie N Mersten, -1

机译：扩展报告：甲磺酸伊马替尼（Gleevec）在治疗弥漫性皮肤系统性硬化症中的作用：一项为期1年的IIa期单臂开放标签临床试验的结果
7. Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study [O] . J. Pope, K. M. Walker, F. de Leon, 2014

机译：从伊马替尼研究中数据使用数据使用数据的活性弥漫性系统硬化症的早期阶段（概念证明）试验之间的相关性与临床结果的相关性

Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.

摘要

著录项

相似文献

相关主题

期刊订阅